Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

OVID

Ovid Therapeutics Inc

May 27 • 04:00PM ET

2.54

+0.09 3.67 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: INCY BMRN VKTX KRYS KYMR NUVL RYTM AXSM MDGL NBIX

| Held by: VTI VXF SURI AVSC BSVO DFAS DFMC PRFZ QQQS DCOR

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.24	Insider Own	10.26%	Shs Outstand	186.64M	Perf Week	5.83%
Market Cap	474.07M	Forward P/E	-	EPS next Y	-0.53	Insider Trans	-0.11%	Shs Float	167.48M	Perf Month	-5.58%
Enterprise Value	331.62M	PEG	-	EPS next Q	-0.12	Inst Own	58.84%	Short Float	5.09%	Perf Quarter	56.79%
Income	-24.17M	P/S	66.58	EPS this Y	-110.00%	Inst Trans	40.87%	Short Ratio	2.64	Perf Half Y	81.43%
Sales	7.12M	P/B	2.14	EPS next Y	-10.42%	ROA	-15.73%	Short Interest	8.53M	Perf YTD	55.83%
Book/sh	1.19	P/C	3.05	EPS next 5Y	-	ROE	-18.77%	52W High	3.11 -18.20%	Perf Year	771.65%
Cash/sh	0.83	P/FCF	-	EPS past 3/5Y	32.53% 29.81%	ROIC	-11.51%	52W Low	0.27 840.39%	Perf 3Y	-28.65%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	68.99% -10.48%	Gross Margin	97.26%	Volatility	4.83% 5.81%	Perf 5Y	-39.95%
Dividend TTM	-	EV/Sales	46.58	EPS Y/Y TTM	30.81%	Oper. Margin	-670.25%	ATR (14)	0.16	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	10.17	Sales Y/Y TTM	1199.64%	Profit Margin	-339.31%	RSI (14)	46.95	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	10.17	EPS Q/Q	13.39%	SMA20	-4.71%	Beta	0.15	Target Price	5.50
Payout	-	Debt/Eq	0.07	Sales Q/Q	-100.00%	SMA50	-2.11%	Rel Volume	0.30	Prev Close	2.45
Employees	23	LT Debt/Eq	0.06	Earnings	May 12 BMO	SMA200	43.69%	Avg Volume	3.24M	Price	2.54
IPO	May 05, 2017	Option/Short	Yes / Yes	EPS/Sales Surpr.	2.83% -100.00%	Trades		Volume	961,910	Change	3.67%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)